FDA takes action on updated mRNA COVID-19 vaccines to better protect against currently circulating variants

Today, the U.S. Food and Drug Administration took action approving and authorizing for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death. Today's actions relate to updated mRNA vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer Inc.

from Breaking World Pharma News https://ift.tt/4XGT3nz